Concepedia

Grishma Acharya

GA

Statistics

Publications

2

Citations

60

H-Index

2

Active since

2019

Affiliations

Prognosys Biosciences (United States)(Current)

Grishma Acharya is an author at Prognosys Biosciences (United States) specializing in oncology, medicine, and programmed cell death protein 1 (pd-1) pathway.

Publications per year

2019–2019

2

Publications

2

The anthelmintic flubendazole blocks human melanoma growth and metastasis and suppresses programmed cell death protein-1 and myeloid-derived suppressor cell accumulation

Yue Li, Grishma Acharya, Mina Elahy et al. · Cancer Letters · 2019 · 38 citations

, , +14

Replication Study: Wnt activity defines colon cancer stem cells and is regulated by the microenvironment

Anthony Essex, Javier Pineda, Grishma Acharya et al. · eLife · 2019 · 22 citations · Full text

, , +17

1–2 of 2